Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week, Multicenter, Open Label Study To Evaluate The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

NCT00571064 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00571064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00571064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week, Multicenter, Open Label Study To Evaluate The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Lead sponsor
Eisai Inc.
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
April 22, 2009
Enrollment
97 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

mild to severe alzheimer's disease